0% found this document useful (0 votes)
56 views31 pages

Gds137 Slide Diabetes Melitus Type 1

This document provides guidelines for the treatment of diabetic ketoacidosis in pediatric patients. It outlines a 14-step protocol for fluid replacement therapy and insulin administration. Key steps include calculating fluid deficits and administration rates, starting an insulin drip, monitoring blood glucose and electrolyte levels regularly, and evaluating the patient and treatment plan every few hours. The goal is to rehydrate the patient and stabilize their blood glucose and electrolyte levels while carefully watching for complications like cerebral edema.

Uploaded by

viscabarca543
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
56 views31 pages

Gds137 Slide Diabetes Melitus Type 1

This document provides guidelines for the treatment of diabetic ketoacidosis in pediatric patients. It outlines a 14-step protocol for fluid replacement therapy and insulin administration. Key steps include calculating fluid deficits and administration rates, starting an insulin drip, monitoring blood glucose and electrolyte levels regularly, and evaluating the patient and treatment plan every few hours. The goal is to rehydrate the patient and stabilize their blood glucose and electrolyte levels while carefully watching for complications like cerebral edema.

Uploaded by

viscabarca543
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 31

DIABETES MELITUS TYPE I

dr. H. Hakimi, Sp.AK dr. H. Charles Darwin Siregar, g Sp.A p dr. Melda Deliana, Sp.AK dr. Siska Mayasari Lubis, Sp.A

PEDIATRIC ENDOCRINOLOGY MEDICAL SCHOOL USU/H. USU/H Adam Malik HOSPITAL Medan

Introduction
Chronic disease Difficult to cure Major DM group in children.

DM Classification based on etiology (ADA,1998)


1 DM type I ( B cell destruction) : 1. a. immune mediated b. idiopathic 2. DM type II (insulin resistant) 3. DM other type a. genetic defect of B cell function b. g genetic defect of insulin function c. pancreas exocrine disease d. endocrinopathy e. drug and chemical substance induction f. Infection g. uncommon immune mediated DM h. Genetic syndrome related to DM 4 DM gestasional 4.

Definition
Systemic disorder because glucose metabolism disorder, characterised by chronic hyperglicemy Caused by y autoimunne p process which destroy pancreas B cell insulin production decrease or stopped

Patogenese
Addison disease
Tirodiditis hashimoto Anemia pernisiosa

Viral infection

Chemical exposure

HLA B8 B8,DR3,BW15,DR4 DR3 BW15 DR4 acti activation ation autoantibody process
langerhans islets destruction

Pancreas B cell function failure Insulin secretion decrease or stop DM type I

diagnostic criteria
Normal blood glucose : <126 mg/dl ( 7 mmol/L) Diagnose is determined if one of this criteria fulfilled :
Polyuria o yu a , polydipsy, po yd psy, polyphagy, po yp agy, decrease dec ease weight eg t , blood glucose ad random >200mg/dl Asymptomatic : blood glucose ad random >200 /dl >200mg/dl

Glucose tolerance test (GTT)


GTT is not nesecary if distinguished symptoms are found Indication I di ti : GTT in i doubtful d btf l case glucose dose : 1,75 gr/W in 200-250 cc water in 5 minutes GTT result intepretation :
DM: fasting blood glucose > 140 mg/dl or at 2nd hour >200 mg /dl Impaired I i d Glucose Gl tolerance t l : fasting f ti blood bl d glucose l <140 nd mg/dl or at 2 hour : 140 199 mg/dl Normal : fasting blood glucose < 110 mg/dl or at 2nd hour : < g 140 mg/dl

Epidemology
Incidence is higher in Caucasian Highest in Finland 43/100.000 , lowest in Japan 2/ 100.000 foo age < 5 yrs old Peak incidence :
Age 5 6 yrs old 11 yrs old

New cases >50% : >20 yrs old Genetic and environment factors : HLA pattern pattern, virus, toxin, etc

Clinical appearance
Acute Polyuria, Polyuria polydypsy, polydypsy rapid weight decrease decrease, hyperglycemy Delayed diagnose : ketoacidosis with all the consequences

DM type I management
Good metabolic control with normal blood glucose level Unified team
Spesific objective 1 optimal growth 1. 2. normal emosional development 3. Good metabolic control without causing hypoglycemy 4. Few school absence days and active in school 5. Patient doesnt doesn t manipulate disease 6. Able to manage disease independently

Objective 1 1. 2. 3. Free from symptoms Enjoy social life Prevent complications

Insulin
Earlier : pig/cow pancreatic gland purification Recombinant technology : human insulin Usage based on age , social economic, culture, and drug distribution Important to know :
somogyi effect dawn d effect ff t Morning hyperglycemy

Insulin
Ultra short acting insulin ( lispro )
Give 15 min before meal Useful in sick day y management g and before meal injection j

Short acting insulin


F For acute stage : ketoacidosis, k id i new patient, i injection i j i before b f meal, and in surgery or combination with medium acting insulin For F toddler t ddl : prevent t hypoglycemy h l

Insulin
Medium acting Insulin
Used twice daily for patient with same daily routine ti pattern tt Widely used in children

Mix Insulin
Standard mixture ( short+medium acting insulin) Good metabolic control For young age child with low education parent

Insulin
Insulin pen Mixing insulin Storage : temp 4 8 oC not in freezer
Type onset (hour) peak(hour) duration(hour)

Ultra short acting short acting g Medium acting Long acting

0,25 0,5 1 1-2 2

1 2-4 4-12 6-20

4 5-8 8-24 18-36

Insulin Regiment
Insulin usage principal Depend p on Indonesia situation and condition Use glucometer and routine daily home testing Objective parameter : Serum HbA1c / 3 months Insulin dose adjustment :
For metabolic control Honeymoon period period, adolescent adolescent, sick days days, surgery

Insulin Injection
Injection technique : subcutaneous with pinchet Self injection Local reaction : rare

Meal adjustment
Objective : achieve good metabolic control without ignoring calory requirement Total calory : 1000 + (age(year)x100) calory per day p y Carbohydrate 60 65% , protein 25%, lipid <30%

Metabolic Control
Metabolic Target(mg/dl) Excellent good moderate poor Preprandial Postprandial Urine reduction HbA1c <120 <140 <7% <140 <200 7-7,9% <180 <240 +-+ 8-9% >180 >240 >+ >10%

Management
Management when diagnosed
Insulin : start 0,5 U/kg/day, gradually adjust education

ketoacidosis management
Insulin Fluid elektrolite balance Acid base balance

Management while surgery Management while Ramadhan fasting Complication C li ti

Complication
Short term complication : hypoglicemy, ketoacidosis Hypoglycemy : blood glucose < 50 mg/dL
neurogenic symptoms Cholinergic Sweating,hungry,numb Adrenergic Tremor tachycardy Tremor, tachycardy, pale, pale Palpitation Palpitation, anxious neuroglycopeny weak, headache, visual disturbance dizziness, tired, sleepy, affective disorder l (depression,angry), coma, convulsion

Long term complication


Retinopathy Nefropathy Growth & development disorder

Hypoglycemy
Prevention P ti
Regular insulin management Regular food intake Parent supervision and education

Therapy py
Mild/moderate hypoglycemy Give 10 20 gr of carbohydrate followed by snack Lemonade e o ade honey o ey glucose g ucose tab tablet et ca can be used Severe hypoglycemy Unconscious / convulsion Oral medication is rarely used shile unconscious Parent education inject glucagon 0,5 mg or 1 mg for child > 5 yrs old

Education
Objective Obj i
Understand the disease Motivation T Type 1 DM management t skill kill Positive attitude Good metabolic control Logic decision of daily management

First education --> at hospital Continous education :


Camp C School

Advice on :
Long L journey j Alkoholic and smoker

Growth and diabetes


Monitor:
B Body d height/3 h i ht/3 months th Body weight Physical and mental development

Psychosocial aspects
Family education Parent training on DM care Advice parent not to give excessive protection

Ketoacidosis Protocol
1.Body weight measurement (kg) 2.Dehidration therapy py decision 3.Calculation of free water deficit 4.Administration of normal saline (0,9NS), bolus if orthostatic or shock occurs 5.Calculate excess of water deficit after the third bolus 6 Calculate maintainance fluid requiremmnt for the 6.Calculate next 48 hours given within 48 hours 7.Calculate total fluid g

Ketoacidosis Protocol
8. Calculate the value of fluid exchange per hour divided by the value on number 7 per 48 hour 9 Make and start regular insulin drip at 0 9. 0,1 1 unit/BW/hour 10.Perform fluid exchange at insulin drip at substract of number 9 from 8 11.Determine fluid type which is used as substitute : - Sodium -patient patient with Na>145mmol/L: 0 0,9NS 9NS -patient with Na<145mmol/L:0,45NS

Ketoacidosis Protocol
-Potassium -Urine (-) : dont give K+ -Urine (+) : add KCL20-40mmol/L -Give K+ as half Chloride/half phophate at first 8 hour -Dextrose - Patient with BG>15mmol/L: dont give dextrose - Patient with BG<15mmol/L: give 5 5-12,5% 12 5% dextrose - Try to maintain BG 10-15mmol/l without adding isulin dose.

Ketoacidosis Protocol
-Bicarbonate : NaHCO3 is not advised 12. Start fluid replacement therapy as mention on umber 11 with the value in number 10 13 Observe neurological signs to see whether cerebral oedem 13.Observe exists. Severe headache, consciousness or blood pressure changes, dilated pupil, bradicardy, postural signs and incontinence Perform rapid intervention (intubate, (intubate mildly hyperventilate, give mannitol 1 gr/kgBB/iv bolus)

Ketoacidosis Protocol
14. Follow laboratorium value: -Follow BG/ 30-60 mnt, whether the child response ? -Follow Na,K,Cl,HCO3, capillary pH value/ 2 4 hrs -Follow Ca and P value if phosphate is given -ReRe check urine glucose and ketone 15. Re- evaluate every fluid change , antisipate the change of K, dextrose, etc value

You might also like